This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Matcheri S. Keshavan, MD
Department of Psychiatry Western Psychiatric Institute and Clinic 3811 O'Hara St Pittsburgh, PA 15213

JAY W. Pettegrew, MD; Kanaka S. Panchalingam, PhD; David Kaplan; Elizabeth Bozik, MD
Pittsburgh, Pa

Arch Gen Psychiatry. 1991;48(12):1112-1113.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Phosphorus 31 magnetic resonance spectroscopy (MRS) is a safe, noninvasive technique that provides information about in vivo metabolism of various tissues, including brain.¹ Using this technique, we have recently gathered data showing that first-episode, neuroleptic-naive schizophrenic patients have altered frontal lobe membrane phospholipid turnover as measured with ³¹P-MRS. Specifically, schizophrenic patients have reduced phosphomonoester levels and increased phosphodiester levels.² Phosphomonoesters are the precursors and phosphodiesters are the breakdown products of membrane phospholipids.^3,4

It is unclear whether the abnormalities in patients affected with schizophrenia represent state or trait alterations. Recently, we examined this issue in a schizophrenic patient who had participated in our ongoing 31P-MRS studies of schizophrenia as a "normal" control prior to her first episode of schizophrenia.

Report of a Case.—

A 31-year-old single woman volunteered as a control in our ³¹P-MRS study. Phosphorus 31 MRS was performed on a . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?